Physician profile
Adrian Theerman
NPI 1295375996
$155.75
in general payments reported to CMS, 2019-2025
8 companies · $51.06 in 2025
The $51.06 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.14 · 2024: $65.55 · 2025: $51.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $116.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $35.82 | 2024 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals Lp | $27.75 | 2024-2025 | Airsupra |
| Novo Nordisk INC | $19.54 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.87 | 2025 | |
| Glaxosmithkline, LLC. | $16.16 | 2021 | |
| Abbvie INC. | $15.63 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.72 | 2021 | |
| Genentech USA, INC. | $9.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrian Theerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.